However, stomach problems were “significantly more common” among youngsters taking the drugs. Experts in the US carried out a review and meta-analysis of 18 trials involving GLP-1 agonists on ...

The once-daily oral GLP-1 RA orforglipron produces clinically and statistically significant weight loss and cardiometabolic improvements, with safety comparable to that of injectable agents.

The H3N2 virus is spreading rapidly across Delhi and nearby areas of NCR cities, where several people are suffering from common flu-like symptoms. A recent health report released by the Local Circles ...

Eli Lilly’s weight-loss pill orforglipron shows major success in Phase 3 trial, helping patients lose up to 12 kg. If ...

Laser surgery for nearsightedness is as safe and effective in older teenagers as it is in adults, researchers reported on ...

A recent study has found that weight loss injections, like Wegovy, Ozempic and Mounjaro, may change how people perceive the ...

Often mistaken for stress or ageing, hypothyroidism can quietly harm health. Here's what to know about its symptoms, risks, ...

A senior Novo Nordisk executive on Wednesday described the drugmaker's ongoing trial of its blockbuster obesity medicine for ...

Polycystic Ovary Syndrome (PCOS) is a common yet often misunderstood condition that impacts women's health, fertility, and ...

WHO is set to recommend weight-loss drugs like Wegovy, Ozempic, and Mounjaro for adults with obesity, calling it a serious ...

A new Lancet study warns that deaths from chronic diseases are rising in India, bucking global trends. Women face a sharper ...

A once-a-day pill for obesity could be a cheaper and more accessible weight-loss drug, after a study found the tablet can lead to “significant” reductions in body weight. More than 60 per cent of ...